BRISBANE, Australia: Australian researchers are currently working on developing a new 3-D bioprinting technology to produce bespoke engineered bone and gingival tissue that can be implanted into the jawbone. If successful, the new procedure would be less painful for patients and have a lower risk of rejection than traditional bone and tissue grafts taken from parts of the body.
The groundbreaking technology, which is currently being developed as part of a three-year study at Griffith University, promises to grow missing bone and tissue from the patient’s own cells. After scanning the affected jaw, a specialised bioprinter is used to fabricate the supporting structures, such as bone, the periodontal ligament and tooth cementum, in one single process, explained Prof. Saso Ivanovski from the university’s Menzies Health Institute Queensland.
The new technology would be a significant improvement over traditional methods, which entail removing bone and tissue from other parts of the body, such as the hip and occasionally the skull, via surgery.
“By using this sophisticated tissue engineering approach, we can instigate a much less invasive method of bone replacement,” Ivanovski remarked. Using structures grown from the cells of the patient also diminishes the risk of rejection and allows the new structure to grow into its surrounding tissue. “At the end of the whole process, you wouldn’t be able to identify what is old bone and new,” he said.
Another advantage of the procedure is that patients from remote locations would not have to travel long distances to visit major clinics for an invasive procedure. Instead, they could have a CT scan of the damaged region done in a regional centre, which could then be sent to a 3-D bioprinter to manufacture a replacement.
The new technology is currently in preclinical trials, and Ivanovski and his team hope to be able to apply this Australian first in humans within the next one to two years.
LOS ANGELES, US: With reported cases as high as 19%, the battle against peri-implantitis has left clinicians and researchers constantly searching for ways ...
NEW YORK, U.S.: It is not uncommon for denture wearers to suffer fungal infections that cause inflammation, redness and swelling in the mouth. Seeking to ...
TOKYO, Japan: In oral and maxillofacial surgery and other fields of dentistry, the use of 3-D patient-specific organ models is increasing, and this has ...
LEEDS, UK: Xerostomia is a prevalent condition especially among older adults, cancer patients and people taking multiple medications. Researchers at the ...
PORTLAND, Ore., U.S.: In a recent development that could have a huge impact on the dental industry, researchers from the Oregon Health and Science ...
ANAHEIM, Calif., US: Oral immunotherapy for peanut allergy entails giving people small amounts of peanuts over time to desensitise them to the legume, thus...
CINCINNATI, US: The prevalence of gingivitis continues to be a significant public health concern, and barriers such as limited access to healthcare and high...
LOS ANGELES, U.S.: Recent studies showing an increase in patients with periodontitis, as well as studies linking it with Alzheimer’s disease, have led to ...
Digital workflows are constantly being improved with innovations in technique, software and materials and tailored to dental diseases and patient cases. ...
PHILADELPHIA, U.S.: The fight against plaque has been a long-running battle. In a discovery that might give dentists the upper edge, researchers from the ...
HALLE, Germany: The environmental impact of microplastics used in personal care products, such as toothpaste, has long been discussed. Tiny plastic ...
Live webinar
Thu. 18 July 2024
8:00 pm EST (New York)
Live webinar
Tue. 6 August 2024
6:00 pm EST (New York)
Live webinar
Tue. 13 August 2024
7:00 pm EST (New York)
Live webinar
Wed. 14 August 2024
12:30 pm EST (New York)
Live webinar
Wed. 21 August 2024
9:00 am EST (New York)
Dr. Jim Lai DMD, MSc(Perio), EdD, FRCD(C)
Live webinar
Wed. 28 August 2024
8:00 pm EST (New York)
Live webinar
Mon. 2 September 2024
5:00 am EST (New York)
To post a reply please login or register